Tag: equity
-
Cell Therapy Mfring Company Raises $82M in Venture Funds
A company developing an automated yet personalized manufacturing platform for cell therapies is raising $82 million in its second venture funding round.
-
Biomanufacturing Materials Company Issues $500M IPO
Zymergen Inc., a developer of materials made with synthetic biology for industrial products is raising $500 million in its initial public stock offering.
-
Microbiome Health Company Raises $40M in Early Funds
A developer of therapies and health products addressing microbes inhabiting the human body is raising $40 million in its first venture funding round.
-
Start-Up Designing Synthetic DNA for Gene Therapies
A new biotechnology company is underway creating gene therapies for inherited diseases delivered with synthetic DNA instead of benign viruses.
-
AI Drug Discovery Company Acquired in $270M Deal
A biotechnology company using protein dynamics to develop precision cancer therapies is acquiring a drug discovery company based on machine learning algorithms.
-
Synthetic DNA Company Raises $24M in Early Funds
A company with a technology it says is simpler and more like natural processes to produce synthetic DNA is raising $24 million in its first venture round.
-
Infographic – Global Venture Funds Hit Record High
Venture investing, a key source of capital for research-based companies, hit a record high level worldwide in the first quarter of 2021.
-
Infectious Disease Biotech Raises $100M in Venture Funds
A biotechnology company designing vaccines for viral diseases including Covid-19 is raising $100 million in its second venture funding round.
-
Microsoft, Biotech Partner on Metastatic Cancer
A biotechnology start-up is collaborating with Microsoft Corp. on computational tools to find and predict factors that cause cancers to spread.
-
Hearing Tech Company Raises New Venture Funds
A company creating devices that help people with hearing impairments, but without the stigma or cost of hearing aids, is raising $7 million in new venture funds.